GR3031801T3 - Vitaletheine and use in cell culture and therapy. - Google Patents

Vitaletheine and use in cell culture and therapy.

Info

Publication number
GR3031801T3
GR3031801T3 GR990402894T GR990402894T GR3031801T3 GR 3031801 T3 GR3031801 T3 GR 3031801T3 GR 990402894 T GR990402894 T GR 990402894T GR 990402894 T GR990402894 T GR 990402894T GR 3031801 T3 GR3031801 T3 GR 3031801T3
Authority
GR
Greece
Prior art keywords
vitaletheine
therapy
cell culture
cell
derivatives
Prior art date
Application number
GR990402894T
Other languages
Greek (el)
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3031801T3 publication Critical patent/GR3031801T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GR990402894T 1990-07-06 1999-11-10 Vitaletheine and use in cell culture and therapy. GR3031801T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54910590A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06
PCT/US1991/004726 WO1992000955A1 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Publications (1)

Publication Number Publication Date
GR3031801T3 true GR3031801T3 (en) 2000-02-29

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402894T GR3031801T3 (en) 1990-07-06 1999-11-10 Vitaletheine and use in cell culture and therapy.

Country Status (9)

Country Link
EP (1) EP0539525B1 (enExample)
JP (1) JP3259960B2 (enExample)
AT (1) ATE186048T1 (enExample)
AU (1) AU655598B2 (enExample)
DE (1) DE69131752T2 (enExample)
DK (1) DK0539525T3 (enExample)
ES (1) ES2139580T3 (enExample)
GR (1) GR3031801T3 (enExample)
WO (1) WO1992000955A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718140B2 (en) * 1995-10-17 2000-04-06 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
JP3319597B2 (ja) * 1990-07-06 2002-09-03 ユニバシテイ オブ ニュー メキシコ 細胞培養及び治療に有用なβ―アレチン

Also Published As

Publication number Publication date
DK0539525T3 (da) 2000-04-10
JPH06500106A (ja) 1994-01-06
JP3259960B2 (ja) 2002-02-25
HK1014367A1 (en) 1999-09-24
DE69131752D1 (de) 1999-12-02
DE69131752T2 (de) 2000-06-29
EP0539525B1 (en) 1999-10-27
ES2139580T3 (es) 2000-02-16
ATE186048T1 (de) 1999-11-15
EP0539525A4 (enExample) 1994-01-12
AU655598B2 (en) 1995-01-05
AU8500891A (en) 1992-02-04
EP0539525A1 (en) 1993-05-05
WO1992000955A1 (en) 1992-01-23

Similar Documents

Publication Publication Date Title
DE60009956D1 (de) Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium
ATE347585T1 (de) In-vitro wachstum von langerhans'schen inseln und ihre verwendungen
BR9910251A (pt) Estimulação hematopoiética
ES8705845A1 (es) Procedimiento de preparar derivados benzonaftalenicos de utilidad terapeutica y cosmetica
EP0283713A3 (en) Complexes of saponins with phospholipids and pharmaceutical and cosmetic compositions containing them
GB2276086A (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
MX9101913A (es) Derivados de quinazolinas para potenciar la actividad antitumoral
ES8605375A1 (es) Un procedimiento para preparar dicha composicion veterinaria a base de bacterias anaerobias y un agente conservador de la eficacia de dichas bacterias.
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ATE330613T1 (de) Verwendung von prostaglandin a oder dessen derivaten zur behandlung von psoriasis
CA2213322A1 (en) Thiols to promote hematopoietic progenitor cell growth
PT862452E (pt) Formulacao de estabilizacao para o ngf
ZA917767B (en) A nutritional composition and a process for its production
EP0380692A4 (en) Plant tissue culture process
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
GR3031801T3 (en) Vitaletheine and use in cell culture and therapy.
GR3018632T3 (en) Beta-alethine use in cell culture and therapy.
DE69110906D1 (de) Verwendung von Wirtszellphospholipiden zur Hemmung bakterieller Besiedlung.
IL131478A0 (en) Methods for treatment of scar tissue
EP0248217A3 (en) Treatment of tumors with autologous lak cells, interleukin-2 and an ornithine decarboxylase inhibitor
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
DE2966082D1 (en) Process for growing human epidermal cells in tissue culture
HU900525D0 (en) Process for the production of medical preparations for treating endotoxinemy
ATE69551T1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
MD460G2 (ro) Procedeu de sinteză a cianocobalaminei